Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data suggest talactoferrin reduces mortality in severe sepsis

June 2, 2010

Phase IIb safety and efficacy data presented on MP-376 in cystic fibrosis

June 2, 2010

Ad3-hTERT-E1A shows favorable clinical safety in solid tumors

June 2, 2010

Auto TAG vaccine shows clinical benefit in advanced cancer

June 2, 2010

GSK-256066 safe and well tolerated in patients with COPD

June 2, 2010

Synergy of ipilimumab and androgen ablation reported in prostate cancer

June 1, 2010

HRH1 gene SNP may predict response to OFC in depressed individuals

June 1, 2010

KB-001 shows clinical promise in P. aeruginosa infection

June 1, 2010

Flibanserin improves HSDD symptoms in premenopausal women

June 1, 2010

Tranexamic acid tablets reduce menstrual blood loss in clinical trials

May 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...